Methods for prognosis, stratification and monitoring of the severity

In the present invention inventors used measured cytokine levels in serum of patients with COVID-19, at the time of hospital admission. Thereafter, […]

Blocking caspase and/or fasl for preventing fataloutcome in covid-19

Herein the inventors demonstrated that CD4 and CD8 T cells from COVID-19 patients are more prone to undergo death and that blocking caspase activation […]

Use of mait cells as biomarkers and biotargets in covid-19

Immune system dysfunction is paramount in Coronavirus disease 2019 (COVID-19) severity and fatality rate. Mucosal-Associated Invariant T (MAIT) cells […]

Use of cd117 as biomarker of worsening in patients suffering from

COVID-19 SARS-CoV-2 infection exhibits a wide inter-individual clinical variability from silent infection to a severe disease and death. To […]

Vaccine model based on recombinant hydrophobic protein and saponin

The Bd37 is an erythrocyte binding protein anchored at the surface of the parasite Babesia divergens. B. divergens is an Apicomplexa parasite, mostly […]

Method for diagnosing brucella infection

Brucella is a facultative intracellular pathogenic bacterium responsible for brucellosis, a worldwide re-emerging zoonotic disease affecting wildlife […]